Abstract
Tenascin X (TNX) was the first non-collagenous molecule of the extracellular matrix that has been shown to be related to Classic Ehlers-Danlos Syndrome (clEDS), a group of heterogeneous disorders characterized by alterations in the biomechanical properties of connective tissues. Patients with clEDS are notably characterized by vascular fragility, which ranges from spontaneous bruising to …